System Formulary Update
Filgrastim-ayow (Releuko)
Situation:
Filgrastim-ayow (Releuko) (300 mcg/0.5 mL PFS and 400 mcg/0.8 mL PFS) injection was approved for addition to the health system formulary at the May 2024 System Pharmacy and Therapeutics Committee meeting.
Background:
The following medication was reviewed: Filgrastim-ayow (Releuko) (300 mcg/0.5 mL PFS and 400 mcg/0.8 mL PFS) injection
Assessment/Recommendations:
System P&T voted to include the following product from the UNC Health Medication Formulary:
Filgrastim-ayow (Releuko) (300 mcg/0.5 mL PFS and 400 mcg/0.8 mL PFS) injection
Note: Stock of this formulary product may vary at individual entities
Formulary/Epic Changes will Go-Live on Tuesday, June 18, 2024